Premium
Bydureon: long‐acting exenatide for once‐weekly injection
Author(s) -
Ballav Chitrabhanu,
Gough Stephen
Publication year - 2012
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.852
Subject(s) - exenatide , medicine , adverse effect , type 2 diabetes , interface (matter) , pharmacology , diabetes mellitus , intensive care medicine , endocrinology , computer science , bubble , maximum bubble pressure method , parallel computing
Bydureon is a long‐acting formulation of exenatide administered as a once‐weekly injection. The authors present the clinical data relating to its efficacy and adverse effects compared with twice‐daily exenatide and other treatments used in type 2 diabetes and discuss its potential role in management. Copyright © 2012 Wiley Interface Ltd
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom